Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Awake DBS Surgery
NCT04716296Completed
- Sponsor
- Rabin Medical Center
- Start
- Jan 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in Parkinson's disease (PD) (2 arms), sponsored by Rabin Medical Center. Primary endpoint: Electrophysiological recordings (MER, Local field potentials and multiunit activity). Started Jan 2021; status: completed.
02
Drugs
ketamine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04716296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04716296.